ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
601 | 52.10999 | 0 | female | 0 | 40 | 1,512 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 21 | null | 44 | 546,390 | 275,272.75 | null | 24.25 | white | 36.195313 | 61 | 0.292969 | 0.181976 | 35 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 40 | 68 | 31.699219 | 110 | 42 | 36.39844 | 135.53125 | 2.5 | 5.399414 | 1.5 | 132 | 7.40918 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
602 | 69.66498 | 1 | male | 0 | 4 | 334 | Lung Cancer | Cancer | 2 | 6 | under $11k | 0 | 9,574 | 4,297.7344 | null | 10 | black | 5.599609 | 20 | 0.866943 | 0.701904 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 109 | 12.5 | 70 | 20 | 36.39844 | null | 4.399414 | 0.199982 | 1.199951 | 136 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
603 | 66.409 | 0 | female | 0 | 11 | 1,511 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | >$50k | 0 | 43,722 | 21,538.375 | null | 17 | white | 22.699219 | 20 | 0.825928 | 0.716919 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 11 | 66 | 7.399414 | 75 | 20 | 36.19531 | null | 2.599609 | 1.299805 | 1 | 131 | null | null | null | null | 5 | 4 | no(M2 and SIP pres) | 4 |
604 | 39.84698 | 1 | female | 0 | 17 | 140 | MOSF w/Malig | ARF/MOSF | 1 | 12 | null | 0 | 47,588 | 22,880.9062 | null | 19 | white | 39.296875 | 24 | 0.20697 | 0.112991 | 3 | 0 | 0 | metastatic | 0.25 | 0.0156 | no dnr | 17 | 71 | 6.199219 | 120 | 22 | 36.39844 | null | null | null | 0.299988 | 111 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.707031 |
605 | 66.14099 | 1 | male | 1 | 8 | 8 | COPD | COPD/CHF/Cirrhosis | 3 | 16 | >$50k | 0 | 21,075 | 9,588.3594 | null | 11 | white | 22.398438 | 38 | 0.831909 | 0.724976 | 1 | 1 | 0 | no | 0.8 | 0.7 | dnr after sadm | 1 | 108 | 14.099609 | 132 | 32 | 36.59375 | 247.8125 | null | null | 1 | 137 | 7.289062 | null | null | null | null | null | <2 mo. follow-up | 4.05957 |
606 | 53.24597 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 26 | 231,587 | 112,461.688 | null | 45 | white | 39.695313 | 76 | 0.287964 | 0.177979 | 18 | 0 | 0 | no | 0.4 | 0.1 | dnr after sadm | 18 | 57 | 24.296875 | 150 | 37 | 36 | 283.625 | null | 15.599609 | 2.299805 | 142 | 7.40918 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
607 | 69.94098 | 1 | male | 0 | 4 | 352 | CHF | COPD/CHF/Cirrhosis | 3 | 18 | >$50k | 0 | 5,631 | 3,324.5644 | null | 7 | white | 21.898438 | 34 | 0.823975 | 0.713989 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 4 | 60 | 8 | 130 | 24 | 35.59375 | 323.75 | null | null | 1.199951 | 138 | 7.539062 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
608 | 20.69299 | 0 | male | 0 | 11 | 1,498 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | null | 0 | 125,185 | 74,128.1875 | null | 16.5 | white | 28.699219 | 47 | 0.845947 | 0.792969 | 6 | 0 | 0 | no | 0.99 | 0.98 | no dnr | 11 | 120 | 16.898438 | 145 | 15 | 36.59375 | 187.75 | null | 0.599976 | 8.898438 | 134 | 7.439453 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
609 | 48.78598 | 0 | female | 0 | 16 | 1,495 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 26 | 96,189 | 48,407.3438 | null | 20 | white | 24.097656 | 44 | 0.770996 | 0.696899 | 3 | 1 | 0 | no | null | null | no dnr | 16 | 127 | 22.796875 | 170 | 32 | 38.29688 | 328 | null | null | 1.299805 | 153 | 7.359375 | null | null | null | null | null | null | 3.588379 |
610 | 35.047 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 155,711 | 74,268 | null | 38 | other | 37 | 66 | 0.28894 | 0.178986 | 21 | 0 | 0 | yes | null | null | dnr after sadm | 6 | 65 | 16.398438 | 125 | 40 | 36.89844 | 237.5 | 3.099609 | 17.398438 | 2.599609 | 139 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 2.303223 |
611 | 72.01398 | 0 | male | 0 | 46 | 1,495 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 0 | 173,394 | 89,319.3125 | null | 17 | white | 27.296875 | 40 | 0.647949 | 0.547974 | 12 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 46 | 110 | 23.296875 | 85 | 40 | 37.89844 | 140.8125 | null | null | 1.899902 | 133 | 7.55957 | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
612 | 42.823 | 1 | female | 1 | 74 | 74 | MOSF w/Malig | ARF/MOSF | 1 | 15 | null | 26 | 393,995 | 182,175.25 | null | 35.75 | white | 38 | 56 | 0.122986 | 0.054993 | 3 | 0 | 0 | metastatic | 0.5 | 0.35 | no dnr | 74 | 67 | 3.299805 | 130 | 50 | 39.59375 | 116.65625 | 2.5 | null | 1.5 | 149 | 7.329102 | null | null | null | null | 1 | Coma or Intub | 1 |
613 | 63.84097 | 1 | female | 0 | 9 | 380 | Colon Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 13,525 | 7,102.8125 | null | 11 | white | 17.5 | 18 | 0.81189 | 0.596924 | 1 | 0 | 0 | metastatic | null | null | no dnr | 9 | 77 | 14.398438 | 100 | 20 | 38.19531 | null | null | 0.399963 | 0.899902 | 132 | null | null | null | null | null | null | null | 2.662598 |
614 | 62.59497 | 1 | female | 0 | 15 | 107 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 26 | 30,117 | 16,954.0781 | null | 11 | white | 17.097656 | 24 | 0.747925 | 0.602905 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 15 | 82 | 7.5 | 78 | 20 | 37.79688 | 457.125 | 2 | 4.399414 | 1 | 132 | 7.519531 | null | null | null | 0 | 1 | adl>=4 (>=5 if sur) | 1 |
615 | 70.823 | 1 | female | 0 | 20 | 26 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 51,017 | 26,579.4688 | null | 16.666656 | white | 19.097656 | 32 | 0.85498 | 0.759888 | 1 | 1 | 0 | no | null | null | no dnr | 20 | 75 | 6.899414 | 70 | 20 | 36 | null | null | null | 2 | 141 | null | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
616 | 60.758 | 1 | female | 0 | 11 | 212 | Colon Cancer | Cancer | 1 | 10 | $25-$50k | 0 | 24,158 | 12,792.6641 | null | 16 | white | 15.199219 | 16 | 0.846924 | 0.662964 | 1 | 0 | 0 | metastatic | null | null | no dnr | 11 | 117 | 11.099609 | 115 | 16 | 36.5 | null | 3.899902 | 0.699951 | 1 | 142 | null | null | null | null | null | null | null | 2.566406 |
617 | 76.03296 | 1 | male | 0 | 8 | 524 | Colon Cancer | Cancer | 0 | 17 | $25-$50k | 0 | 14,594 | 7,638.6875 | null | 12 | white | 17.5 | 21 | 0.78894 | 0.555908 | 1 | 0 | 0 | metastatic | null | null | no dnr | 8 | 110 | 13.398438 | 104 | 24 | 38.59375 | null | null | null | 1.199951 | 136 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
618 | 62.42599 | 1 | male | 0 | 4 | 835 | Lung Cancer | Cancer | 1 | null | null | 0 | 9,366 | 3,919.8184 | null | 10 | white | 15.5 | 9 | 0.741943 | 0.47699 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 83 | 12.798828 | 78 | 20 | 36.39844 | null | null | null | 1 | 138 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
619 | 58.58197 | 1 | male | 0 | 8 | 168 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 44,079 | 24,343.4219 | null | 12 | black | 14.099609 | 23 | 0.828979 | 0.720947 | 11 | 0 | 0 | no | null | null | no dnr | 8 | 67 | 8.398438 | 76 | 20 | 37.89844 | null | null | null | 1.5 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.112793 |
620 | 38.155 | 1 | male | 0 | 21 | 1,050 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 16 | under $11k | 100 | 143,906 | 70,408.9375 | null | 27 | white | 29.898438 | 39 | 0.316956 | 0.202972 | 10 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 21 | 73 | 13.199219 | 60 | 10 | 36.59375 | 142 | 2.5 | 0.599976 | 6.5 | 131 | 7.379883 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
621 | 79.97797 | 1 | female | 1 | 37 | 37 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | null | 26 | 214,894 | 94,687 | null | 34.75 | white | 38.695313 | 61 | 0.209991 | 0.11499 | 3 | 0 | 0 | no | null | null | no dnr | 37 | 64 | 25.5 | 111 | 40 | 36.5 | 105 | null | 0.799927 | 2.399902 | 129 | 7.369141 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
622 | 72.71497 | 0 | female | 0 | 17 | 1,490 | CHF | COPD/CHF/Cirrhosis | 1 | 14 | $11-$25k | 0 | 76,132 | 37,674.5625 | null | 10.666664 | black | 19.296875 | 31 | 0.845947 | 0.746948 | 1 | 0 | 0 | no | null | null | no dnr | 17 | 105 | 7.5 | 110 | 26 | 36.5 | null | null | null | 1 | 138 | null | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
623 | 65.53894 | 0 | female | 0 | 6 | 1,490 | Lung Cancer | Cancer | 2 | 14 | $25-$50k | 0 | 7,769 | 3,896.7402 | null | 10 | white | 15.798828 | 12 | 0.730957 | 0.459961 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 125 | 9.599609 | 88 | 22 | 36.39844 | null | null | null | 0.799927 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
624 | 50.439 | 1 | male | 0 | 8 | 178 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 16,863 | 8,925.1484 | null | 10.5 | black | 32.195313 | 48 | 0.72998 | 0.645996 | 1 | 1 | 0 | no | 0.8 | 0.7 | dnr after sadm | 3 | 82 | 2.099609 | 60 | 26 | 36 | 366.625 | null | 1.299805 | 9.099609 | 130 | 7.489258 | null | null | null | 1 | null | null | 1.1669 |
625 | 61.02698 | 0 | male | 0 | 10 | 1,488 | Colon Cancer | Cancer | 1 | 13 | null | 0 | 31,943 | 16,502.6094 | null | 16.5 | white | 11.099609 | 38 | 0.886963 | 0.743896 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 10 | 100 | 10.199219 | 128 | 28 | 38.19531 | null | 3.799805 | 2.299805 | 1.199951 | 140 | null | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
626 | 66.37097 | 0 | male | 0 | 15 | 1,486 | CHF | COPD/CHF/Cirrhosis | 0 | 12 | $25-$50k | 0 | 50,099 | 25,124.25 | null | 14.666664 | white | 26.5 | 42 | 0.753906 | 0.610962 | 2 | 0 | 0 | no | null | null | no dnr | 15 | 57 | 11.599609 | 115 | 24 | 36.59375 | null | null | null | 1.599854 | 130 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
627 | 54.08899 | 1 | female | 1 | 9 | 9 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 23,806 | 10,995.6953 | null | 10 | white | 30.5 | 35 | 0.393982 | 0.099991 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 4 | 87 | 27.597656 | 128 | 30 | 36.19531 | 136.65625 | null | null | 0.799927 | 138 | 7.479492 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
628 | 75.26398 | 1 | female | 0 | 38 | 118 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | null | 0 | 444,915 | 211,648.875 | null | 20.5 | white | 24.898438 | 41 | 0.660889 | 0.562988 | 56 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 38 | 63 | 12.5 | 115 | 40 | 36.59375 | 195 | 3.299805 | null | 1.099854 | 142 | 7.269531 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
629 | 31.72099 | 1 | male | 0 | 10 | 505 | MOSF w/Malig | ARF/MOSF | 2 | 20 | null | 26 | 58,405 | 28,456.5938 | null | 18.5 | white | 24.699219 | 31 | 0.487 | 0.368958 | 5 | 0 | 0 | metastatic | null | null | no dnr | 10 | 73 | 7.5 | 110 | 28 | 36.29688 | 149.0625 | 2.799805 | 0.899902 | 1 | 134 | 7.449219 | null | null | null | null | 0 | null | 0 |
630 | 80.01099 | 1 | male | 0 | 12 | 45 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | $25-$50k | 44 | 50,808 | 23,158.7031 | null | 25.5 | white | 19.296875 | 27 | 0.671997 | 0.576904 | 2 | 0 | 0 | no | 0.25 | 0.1 | dnr after sadm | 1 | 63 | 15.298828 | 100 | 28 | 38 | 277.75 | null | null | 1.099854 | 148 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 3.078613 |
631 | 83.59497 | 0 | male | 0 | 13 | 1,484 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 19 | >$50k | 0 | 81,350 | 38,778.9062 | null | 21 | white | 25.5 | 38 | 0.661987 | 0.563965 | 4 | 1 | 0 | no | null | null | no dnr | 13 | 110 | 14.699219 | 130 | 28 | 37 | 195.90625 | null | null | 1 | 133 | 7.489258 | null | null | null | 0 | 0 | null | 0 |
632 | 43.64697 | 1 | female | 0 | 59 | 234 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 26 | 528,848 | 276,147.5 | null | 30.25 | white | 29.199219 | 38 | 0.634888 | 0.532959 | 31 | 0 | 0 | no | null | null | no dnr | 59 | 110 | 18.699219 | 110 | 8 | 36.69531 | 390 | 2.399902 | 0.699951 | 2.5 | 127 | 7.399414 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.742188 |
633 | 38.12198 | 1 | female | 0 | 6 | 956 | Lung Cancer | Cancer | 1 | null | null | 0 | 8,624 | 5,387.1914 | null | 7 | white | 12.599609 | 11 | 0.828979 | 0.628906 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 76 | 4.699219 | 82 | 20 | 37.19531 | null | null | 0.299988 | 0.899902 | 138 | null | null | null | null | null | null | null | 2.130371 |
634 | 79.07495 | 0 | female | 0 | 15 | 1,482 | CHF | COPD/CHF/Cirrhosis | 1 | 7 | null | 0 | 24,141 | 13,296.5859 | null | 5 | white | 19 | 27 | 0.828979 | 0.720947 | 1 | 0 | 0 | no | null | null | no dnr | 15 | 97 | 5.799805 | 76 | 20 | 36.79688 | null | null | null | 2.699707 | 139 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
635 | 84.91199 | 1 | male | 1 | 16 | 16 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 9 | 30,383 | 15,251.25 | null | 10.333328 | white | 22.699219 | 30 | 0.495972 | 0.294983 | 1 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 10 | 83 | 9.199219 | 72 | 20 | 36 | null | 2.5 | null | 2.099609 | 129 | null | null | null | null | 2 | 1 | <2 mo. follow-up | 1 |
636 | 74.64795 | 1 | male | 1 | 6 | 6 | Coma | Coma | 1 | 8 | under $11k | 94 | 34,042 | 17,106.8125 | null | 42 | white | 28.199219 | 27 | 0.068985 | 0.037994 | 1 | 0 | 0 | no | 0.01 | 0.000001 | dnr after sadm | 3 | 43 | 33.195313 | 70 | 12 | 38 | 205.6875 | 3 | null | 1 | 135 | 7.469727 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
637 | 56.271 | 0 | male | 0 | 6 | 1,481 | Lung Cancer | Cancer | 1 | 16 | null | 0 | 15,227 | 8,136.6094 | null | 13 | white | 17.597656 | 13 | 0.716919 | 0.437988 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 75 | 11.199219 | 104 | 22 | 38.19531 | 426.0625 | null | null | 0.899902 | 134 | 7.369141 | null | null | null | null | null | no(M2 and SIP pres) | 2.373535 |
638 | 75.23096 | 1 | male | 0 | 12 | 992 | CHF | COPD/CHF/Cirrhosis | 1 | 20 | $25-$50k | 0 | 29,545 | 15,882.1641 | null | 17 | white | 19.097656 | 34 | 0.840942 | 0.738892 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 68 | 6.599609 | 70 | 24 | 36.69531 | null | null | null | 2.299805 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
639 | 40.53098 | 0 | female | 0 | 11 | 1,481 | Colon Cancer | Cancer | 2 | 11 | >$50k | 0 | 26,039 | 13,825.3984 | null | 12.5 | hispanic | 3.5 | 5 | 0.949951 | 0.880981 | 1 | 0 | 0 | metastatic | 0.98 | 0.95 | no dnr | 11 | 97 | 4.299805 | 70 | 14 | 37.89844 | null | 4.399414 | 1.199951 | 0.799927 | 140 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.20459 |
640 | 74.40094 | 1 | male | 1 | 4 | 4 | CHF | COPD/CHF/Cirrhosis | 4 | 15 | >$50k | 41 | 22,733 | 11,903.5234 | null | 32 | white | 24.597656 | 49 | 0.618896 | 0.432983 | 1 | 1 | 0 | no | null | null | dnr after sadm | 2 | 57 | 19.398438 | 50 | 26 | 38.19531 | 436.6875 | null | 0.799927 | 2.199707 | 139 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 3.560059 |
641 | 77.67596 | 1 | female | 0 | 12 | 59 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | $11-$25k | 0 | null | null | null | 23 | black | 20.398438 | 23 | 0.699951 | 0.609985 | 2 | 0 | 0 | metastatic | null | null | no dnr | 12 | 85 | 11.398438 | 110 | 20 | 36.89844 | 260 | 2.5 | null | 1.199951 | 134 | 7.449219 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
642 | 68.24597 | 0 | male | 0 | 25 | 1,478 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 162,892 | 85,360.375 | null | 19.25 | asian | 40.296875 | 61 | 0.29895 | 0.186981 | 21 | 1 | 0 | no | null | null | no dnr | 25 | 117 | 17.898438 | 35 | 20 | 36 | 93.875 | null | 1.299805 | 4.899414 | 131 | 7.529297 | null | null | null | null | null | null | 3.179199 |
643 | 38.32999 | 0 | male | 0 | 5 | 1,479 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 6,062 | 4,049.2051 | null | 9 | white | 16.199219 | 19 | 0.91394 | 0.85498 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 113 | 8.898438 | 72 | 20 | 37 | null | null | 3.899902 | 1 | 141 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.168945 |
644 | 48.36697 | 0 | male | 0 | 16 | 1,477 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $11-$25k | 26 | 74,504 | 33,867.0938 | null | 20.333328 | white | 19 | 24 | 0.842896 | 0.78894 | 3 | 0 | 0 | no | 0.98 | 0.98 | no dnr | 16 | 80 | 8.298828 | 115 | 28 | 39.39844 | 272.5 | 2.799805 | 0.799927 | 1.299805 | 141 | 7.509766 | null | null | null | null | null | no(M2 and SIP pres) | 2.277344 |
645 | 80.87598 | 0 | female | 0 | 46 | 1,477 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $25-$50k | 0 | 147,296 | 76,390.875 | null | 21.75 | white | 26.398438 | 43 | 0.702881 | 0.612915 | 1 | 0 | 0 | no | null | null | no dnr | 46 | 113 | 26.199219 | 119 | 24 | 38.19531 | 177.53125 | 1.899902 | 1.599854 | 1.899902 | 135 | 7.449219 | null | null | null | null | 0 | null | 0 |
646 | 63.38699 | 1 | male | 0 | 3 | 39 | Lung Cancer | Cancer | 1 | null | null | 0 | 7,253 | 3,041.6543 | null | 9 | white | 16.398438 | 15 | 0.7229 | 0.447998 | 1 | 0 | 0 | metastatic | 0.75 | 0.15 | no dnr | 3 | 79 | 12.398438 | 82 | 20 | 36.39844 | null | null | null | 0.899902 | 135 | null | null | null | null | null | null | <2 mo. follow-up | 2.316895 |
647 | 60.03598 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 142,731 | 62,150.5 | null | 43.5 | white | 31.199219 | 50 | 0.560913 | 0.448975 | 3 | 1 | 0 | no | null | null | no dnr | 10 | 60 | 13.298828 | 125 | 8 | 38.5 | 138.15625 | null | 0.799927 | 3 | 137 | 7.569336 | null | null | null | null | null | <2 mo. follow-up | 2.795898 |
648 | 71.45197 | 1 | female | 0 | 10 | 1,114 | COPD | COPD/CHF/Cirrhosis | 1 | 10 | under $11k | 0 | 29,501 | 14,482.2031 | null | 11.5 | white | 25.597656 | 24 | 0.75 | 0.605957 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 10 | 87 | 15.199219 | 78 | 26 | 36 | 200 | null | null | 1 | 125 | 7.299805 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
649 | 32.95297 | 0 | female | 0 | 8 | 1,461 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 41 | 42,572 | 22,324.5938 | null | 23.5 | white | 33.796875 | 50 | 0.631958 | 0.529907 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 8 | 122 | 5.799805 | 110 | 45 | 39 | 194.28125 | 2.699707 | 9.298828 | 0.5 | 151 | 7.5 | null | null | null | null | null | null | 3.178711 |
650 | 39.63898 | 0 | male | 0 | 48 | 1,460 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 13 | null | 0 | 272,602 | 133,509.5 | null | 13.75 | white | 42.09375 | 59 | 0.463989 | 0.262939 | 1 | 0 | 0 | no | null | null | no dnr | 48 | 71 | 34.398438 | 80 | 20 | 36.39844 | 404.75 | 2.5 | 29.597656 | 5.899414 | 122 | 7.30957 | null | null | null | 5 | 0 | SIP>=30 | 0 |
651 | 85.11694 | 1 | male | 0 | 7 | 11 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | $11-$25k | 0 | 15,112 | 7,727.9297 | null | 12 | white | 25.597656 | 42 | 0.626953 | 0.44397 | 1 | 0 | 0 | yes | 0.75 | 0.5 | dnr after sadm | 2 | 66 | 9.199219 | 70 | 28 | 36 | null | 3.799805 | 0.899902 | 3.199707 | 128 | null | null | null | null | null | 3 | <2 mo. follow-up | 3 |
652 | 68.87299 | 1 | female | 1 | 3 | 3 | Lung Cancer | Cancer | 1 | 18 | under $11k | 41 | 9,982 | 5,144.9805 | null | 12 | white | 37.59375 | 47 | 0.031998 | 0 | 1 | 0 | 0 | metastatic | 0.05 | 0.000125 | dnr after sadm | 1 | 72 | 14.5 | 124 | 40 | 36.39844 | 147.5 | 2.899902 | 0.099991 | 0.399963 | 138 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 3.471191 |
653 | 77.13599 | 1 | male | 1 | 8 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 19 | $11-$25k | 9 | 42,561 | 21,488.2344 | null | 30 | white | 29.5 | 57 | 0.380981 | 0.185974 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 7 | 93 | 10.398438 | 96 | 11 | 36.19531 | 236.71875 | 2.899902 | 9 | 1.899902 | 134 | 7.509766 | null | null | null | null | null | <2 mo. follow-up | 3.370117 |
654 | 61.99597 | 0 | male | 0 | 9 | 1,458 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 26,184 | 13,366.4375 | null | 13.5 | white | 20.5 | 31 | 0.86499 | 0.776978 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 66 | 5.799805 | 70 | 26 | 36 | null | null | 1.299805 | 1.399902 | 131 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
655 | 50.97598 | 0 | male | 0 | 18 | 1,457 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 16 | >$50k | 0 | 93,205 | 41,622.8438 | null | 25.333328 | white | 28.5 | 35 | 0.790894 | 0.721924 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 8 | 138 | 14.298828 | 120 | 16 | 38.29688 | 84 | 3.599609 | 1.199951 | 1.199951 | 143 | 7.439453 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
656 | 53.45898 | 1 | female | 1 | 132 | 132 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $25-$50k | 0 | 1,057,324 | 483,556.25 | null | 29.5 | white | 35.5 | 61 | 0.595947 | 0.487976 | 4 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 128 | 63 | 4.599609 | 75 | 24 | 36.29688 | 270 | 3.299805 | 29.699219 | 5.099609 | 137 | 7.469727 | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
657 | 70.93994 | 1 | male | 0 | 7 | 1,349 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 20,186 | 10,203.7812 | null | 19 | asian | 19.699219 | 37 | 0.846924 | 0.748901 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 7 | 57 | 6.5 | 60 | 28 | 36.39844 | null | null | null | 1.299805 | 137 | null | null | null | null | 0 | 0 | null | 0 |
658 | 89.77399 | 1 | male | 0 | 4 | 454 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 5,897 | 3,399.334 | null | 6 | white | 18.398438 | 30 | 0.797974 | 0.674927 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 120 | 7.899414 | 104 | 27 | 36.39844 | null | null | 0.199982 | 1.199951 | 136 | null | null | null | null | 2 | null | null | 1.839 |
659 | 81.67596 | 1 | female | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 41 | 125,968 | 60,127.875 | null | 39.333313 | white | 28.199219 | 39 | 0.472961 | 0.353943 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 13 | 58 | 16 | 60 | 10 | 37.19531 | 74.4375 | null | null | 0.899902 | 135 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 3.727539 |
660 | 59.10199 | 1 | male | 0 | 8 | 25 | CHF | COPD/CHF/Cirrhosis | 3 | 7 | $25-$50k | 0 | 34,775 | 17,118.25 | null | 18.5 | hispanic | 24.398438 | 45 | 0.828979 | 0.721924 | 1 | 0 | 0 | no | null | null | no dnr | 8 | 55 | 8.099609 | 85 | 28 | 36.29688 | null | 3.199707 | 3 | 1.299805 | 134 | null | null | null | null | 2 | 2 | <2 mo. follow-up | 2 |
661 | 56.64099 | 1 | female | 0 | 8 | 1,022 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 20,497 | 11,364.9922 | null | 9 | white | 16.699219 | 22 | 0.879883 | 0.836914 | 1 | 0 | 0 | yes | null | null | no dnr | 8 | 100 | 10.099609 | 100 | 24 | 37 | 271.375 | 4.5 | 0.399963 | 0.899902 | 140 | 7.379883 | null | null | null | null | 5 | no(M2 and SIP pres) | 5 |
662 | 67.37 | 1 | female | 0 | 20 | 77 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 50,138 | 27,878.3281 | null | 10.333328 | white | 21.699219 | 36 | 0.715942 | 0.557983 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 6 | 71 | 4.399414 | 72 | 20 | 36.39844 | null | 2.599609 | 1.899902 | 4.699219 | 140 | null | null | null | null | 5 | null | adl>=4 (>=5 if sur) | 3.855299 |
663 | 57.46698 | 1 | male | 1 | 33 | 33 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $11-$25k | 0 | 150,471 | 73,386.0625 | null | 21.25 | asian | 33.296875 | 41 | 0.540894 | 0.425964 | 5 | 0 | 0 | yes | 0.8 | 0.75 | dnr after sadm | 21 | 73 | 15.599609 | 120 | 16 | 36.5 | 83.67188 | null | 3.799805 | 0.799927 | 141 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 3.263672 |
664 | 68.87897 | 1 | female | 0 | 12 | 57 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 65,136 | 31,077.1094 | null | 21.5 | black | 28.097656 | 50 | 0.725952 | 0.640991 | 1 | 1 | 0 | no | 0.6 | 0.4 | no dnr | 12 | 80 | 25.898438 | 115 | 28 | 36.89844 | null | 2.199707 | 0.399963 | 2 | 129 | null | null | null | null | null | null | <2 mo. follow-up | 3.728027 |
665 | 35.806 | 0 | female | 0 | 5 | 1,448 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 20,092 | 10,231.5 | null | 18 | white | 27.699219 | 42 | 0.863892 | 0.775879 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 50 | 8.699219 | 135 | 24 | 35.89844 | null | 3.899902 | 0.799927 | 1.599854 | 134 | null | null | null | null | null | null | null | 2.154297 |
666 | 35.603 | 1 | male | 0 | 11 | 814 | Colon Cancer | Cancer | 1 | null | null | 0 | 41,788 | 20,779.6094 | null | 12.5 | white | 27.398438 | 25 | 0.711914 | 0.430969 | 1 | 0 | 0 | metastatic | null | null | no dnr | 11 | 79 | 25.597656 | 120 | 22 | 39.59375 | null | 3.099609 | 0.399963 | 0.799927 | 133 | null | null | null | null | null | null | null | 2.93457 |
667 | 43.47699 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | $11-$25k | 26 | 79,576 | 37,880.3438 | null | 44.5 | hispanic | 46.695313 | 68 | 0.274963 | 0.166992 | 1 | 0 | 0 | no | null | null | dnr after sadm | 8 | 48 | 5.599609 | 130 | 20 | 37.5 | 130 | 2.299805 | 21.097656 | 1.399902 | 130 | 7.589844 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
668 | 58.68597 | 0 | male | 0 | 7 | 1,446 | CHF | COPD/CHF/Cirrhosis | 1 | 14 | under $11k | 0 | 16,964 | 9,183.4531 | null | 16 | white | 13.798828 | 30 | 0.924927 | 0.871948 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 7 | 57 | 10.599609 | 75 | 24 | 36.29688 | null | 4.399414 | 0.5 | 1.299805 | 132 | null | null | null | null | 0 | 0 | null | 0 |
669 | 44.60797 | 1 | female | 1 | 9 | 9 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 41 | 214,817 | 115,186 | null | 20 | hispanic | 25.296875 | 36 | 0.546997 | 0.348999 | 58 | 0 | 0 | no | 0.2 | 0.05 | dnr after sadm | 5 | 120 | 12.398438 | 115 | 12 | 38.29688 | 280 | null | 9.599609 | 0.799927 | 137 | 7.489258 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
670 | 70.04797 | 0 | male | 0 | 14 | 1,445 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | $25-$50k | 0 | 26,738 | 14,451.3594 | null | 10 | white | 14.5 | 36 | 0.815918 | 0.700928 | 1 | 0 | 0 | no | null | null | no dnr | 14 | 63 | 6.299805 | 74 | 20 | 36.39844 | 266.625 | 1.599854 | 1.099854 | 1.199951 | 135 | 7.529297 | null | null | null | null | 1 | null | 1 |
671 | 45.043 | 1 | female | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | null | 44 | 194,716 | 93,609.625 | null | 31 | white | 35.796875 | 74 | 0.461975 | 0.342957 | 2 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 12 | 128 | 0.299988 | 115 | 38 | 36 | 250 | 2.199707 | 0.699951 | 2.199707 | 148 | 7.469727 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
672 | 60.79398 | 1 | female | 0 | 20 | 136 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | null | 26 | 141,714 | 67,726.3125 | null | 31.333328 | white | 29.296875 | 55 | 0.556885 | 0.444946 | 10 | 0 | 0 | no | null | null | no dnr | 20 | 59 | 12.898438 | 155 | 28 | 38.59375 | 119.98438 | null | 1.199951 | 0.899902 | 137 | 7.5 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
673 | 55.88199 | 1 | female | 0 | 3 | 574 | Lung Cancer | Cancer | 1 | 14 | under $11k | 0 | 6,593 | 2,757.2383 | null | 9 | black | 13.798828 | 5 | 0.783936 | 0.545898 | 1 | 0 | 0 | metastatic | 0.9 | 0.75 | dnr after sadm | 1 | 94 | 8 | 88 | 20 | 37 | null | null | null | 1 | 138 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.224121 |
674 | 65.02899 | 1 | female | 0 | 3 | 35 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 3,087 | 2,025.5361 | null | 7 | black | 24.398438 | 35 | 0.707886 | 0.547974 | 1 | 1 | 0 | metastatic | 1 | 0.3 | no dnr | 3 | 103 | null | 68 | 26 | 35.79688 | 471.375 | null | null | 1.5 | 126 | 7.5 | null | null | null | 2 | 6 | <2 mo. follow-up | 6 |
675 | 19.17 | 0 | female | 0 | 30 | 1,440 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 166,750 | 79,628.75 | null | 29.25 | hispanic | 50.296875 | 86 | 0.44696 | 0.245972 | 1 | 0 | 0 | yes | 0.5 | 0.1 | no dnr | 30 | 46 | 16.199219 | 170 | 47 | 36 | 31.66406 | null | null | 1.599854 | 131 | 7.189453 | null | null | null | null | null | null | 2.340332 |
676 | 72.84296 | 1 | female | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 196,869 | 94,460.75 | null | 50.5 | white | 33 | 38 | 0.35199 | 0.234985 | 16 | 0 | 0 | no | null | null | no dnr | 11 | 50 | 10.199219 | 120 | 10 | 36.79688 | 188 | 3 | null | 1 | 127 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 2.65625 |
677 | 42.03699 | 1 | male | 1 | 28 | 28 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 20 | >$50k | 0 | 100,295 | 48,086.9375 | null | 16.25 | white | 29.796875 | 59 | 0.738892 | 0.589966 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 28 | 77 | 6.799805 | 82 | 20 | 36.39844 | null | 1.399902 | 17.296875 | 2 | 128 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
678 | 59.806 | 0 | female | 0 | 21 | 1,437 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | $25-$50k | 26 | 75,895 | 34,792.25 | null | 15.333328 | asian | 23.597656 | 32 | 0.721924 | 0.566895 | 2 | 0 | 0 | yes | 0.6 | 0.4 | no dnr | 21 | 128 | 13.699219 | 145 | 26 | 37 | 222.84375 | null | null | 0.699951 | 143 | 7.349609 | null | null | null | null | 0 | null | 0 |
679 | 49.56097 | 1 | male | 1 | 32 | 32 | Coma | Coma | 1 | 16 | >$50k | 44 | 245,849 | 101,754.438 | null | 36.5 | black | 30 | 50 | 0.355957 | 0.282959 | 17 | 1 | 0 | no | null | null | dnr after sadm | 13 | 102 | 22.398438 | 100 | 12 | 38.29688 | 154 | null | 2.099609 | 2.199707 | 129 | 7.539062 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
680 | 51.93997 | 1 | male | 0 | 39 | 1,072 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 37 | 280,893 | null | null | 32 | white | 28.699219 | 42 | 0.359985 | 0.241974 | 5 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 9 | 63 | 5.699219 | 110 | 18 | 39.19531 | 172 | null | 3.299805 | 2.099609 | 140 | 7.459961 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
681 | 55.24698 | 1 | female | 0 | 4 | 235 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 6,536 | 3,746.0566 | null | 7 | white | 15 | 16 | 0.922974 | 0.869995 | 1 | 1 | 0 | no | null | null | no dnr | 4 | 87 | 9.199219 | 84 | 20 | 36 | 257.125 | null | 0.5 | 1.199951 | 140 | 7.509766 | null | null | null | 2 | null | null | 1.839 |
682 | 73.75494 | 1 | male | 0 | 6 | 35 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 44 | 29,426 | 13,739.3125 | null | 23 | black | 34.398438 | 68 | 0.121994 | 0.053993 | 1 | 1 | 0 | metastatic | 0.05 | 0.000125 | dnr after sadm | 1 | 50 | 17.398438 | 104 | 28 | 38.39844 | 158.3125 | 2 | 0.5 | 2.099609 | 153 | 7.199219 | null | null | null | null | null | <2 mo. follow-up | 3.889648 |
683 | 47.93198 | 1 | female | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 0 | 92,238 | 45,525.5312 | null | 45 | white | 46.296875 | 83 | 0.026997 | 0.007 | 21 | 0 | 0 | metastatic | 0.2 | 0.1 | dnr after sadm | 4 | 60 | 0.049995 | 150 | 40 | 36.29688 | 167.34375 | 2.599609 | 2.199707 | 2.899902 | 129 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 3.251953 |
684 | 58.69699 | 1 | female | 0 | 3 | 1,086 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 6,849 | 3,490.2266 | null | 4 | hispanic | 19.398438 | 40 | 0.883911 | 0.806885 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 100 | 5.899414 | 80 | 28 | 36.59375 | 352.375 | null | null | 2.199707 | 138 | 7.40918 | null | null | null | null | null | SIP>=30 | 2.371582 |
685 | 60.73099 | 0 | male | 0 | 50 | 1,434 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | null | 26 | 363,112 | 186,497.75 | null | 28.75 | hispanic | 25.398438 | 56 | 0.642944 | 0.541992 | 15 | 0 | 0 | no | null | null | no dnr | 50 | 107 | 8.099609 | 70 | 24 | 36.29688 | 315 | 2.799805 | 11.898438 | 8.199219 | 142 | 7.469727 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
686 | 68.50397 | 1 | male | 0 | 9 | 338 | MOSF w/Malig | ARF/MOSF | 2 | 16 | >$50k | 9 | 41,674 | 19,016.3594 | null | 23 | white | 23.296875 | 32 | 0.652954 | 0.553955 | 2 | 0 | 0 | yes | 0.7 | 0.6 | no dnr | 9 | 69 | 3 | 70 | 26 | 38.19531 | 231.40625 | null | 2.399902 | 1.199951 | 131 | 7.459961 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
687 | 41.75497 | 1 | female | 1 | 6 | 6 | Coma | Coma | 6 | 16 | >$50k | 100 | 69,323 | 33,539.1875 | null | 36 | white | 42.09375 | 60 | 0.016998 | 0.007 | 3 | 1 | 0 | no | null | null | dnr after sadm | 6 | 40 | 31.597656 | 120 | 26 | 38.59375 | 260 | null | null | 3.799805 | 146 | 7.599609 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
688 | 48.14798 | 0 | male | 0 | 4 | 1,432 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 23,166 | 11,004.8984 | null | 11 | white | 23.898438 | 9 | 0.846924 | 0.793945 | 2 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 4 | 78 | 14.099609 | 82 | 18 | 36.79688 | 86 | null | 0.699951 | 1 | 138 | 7.40918 | null | null | null | null | null | null | 2.194824 |
689 | 48.564 | 1 | male | 0 | 44 | 181 | MOSF w/Malig | ARF/MOSF | 2 | 19 | null | 0 | 225,659 | 108,896.062 | null | 20 | white | 31.199219 | 49 | 0.437988 | 0.317993 | 18 | 0 | 0 | yes | null | null | no dnr | 44 | 103 | 0.099991 | 110 | 20 | 39.5 | 208.15625 | 2 | null | 1.399902 | 131 | 7.509766 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
690 | 45.51398 | 1 | male | 1 | 39 | 39 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 16 | >$50k | 0 | 323,371 | 183,641.75 | null | 7 | asian | 27.597656 | 46 | 0.754883 | 0.611938 | 1 | 0 | 0 | no | 0.8 | 0.4 | dnr after sadm | 39 | 94 | 9.199219 | 82 | 18 | 36.19531 | null | 1.899902 | 11.199219 | 1.399902 | 126 | null | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
691 | 82.66699 | 1 | female | 0 | 27 | 128 | Coma | Coma | 3 | 12 | under $11k | 55 | 130,916 | 66,110.1875 | null | 18.75 | white | 26.597656 | 23 | 0.072998 | 0.040993 | 5 | 0 | 1 | yes | 0.2 | 0.2 | dnr after sadm | 3 | 112 | 79.1875 | 55 | 18 | 38.5 | 212.5 | null | null | 0.699951 | 125 | 7.519531 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
692 | 42.45599 | 0 | male | 0 | 20 | 1,430 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | >$50k | 26 | 63,445 | 31,127.625 | null | 16.666656 | hispanic | 18 | 30 | 0.868896 | 0.822998 | 3 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 20 | 113 | 9.199219 | 110 | 33 | 38.29688 | 220 | null | 0.299988 | 0.799927 | 137 | 7.469727 | null | null | null | null | 0 | SIP>=30 | 0 |
693 | 70.20898 | 1 | male | 0 | 6 | 452 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 9,088 | 4,997.6172 | null | 10 | white | 15.199219 | 15 | 0.731934 | 0.460999 | 1 | 0 | 0 | metastatic | 0.65 | 0.5 | no dnr | 6 | 111 | 12.199219 | 80 | 22 | 36.59375 | null | null | null | 1 | 137 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
694 | 40.39999 | 1 | male | 0 | 4 | 130 | Lung Cancer | Cancer | 3 | null | null | 0 | 12,693 | 5,611.8125 | null | 11 | white | 17 | 6 | 0.761963 | 0.509888 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 4 | 90 | 6.299805 | 104 | 18 | 36.59375 | null | null | null | 0.899902 | 139 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.730957 |
695 | 76.08997 | 1 | male | 0 | 7 | 240 | CHF | COPD/CHF/Cirrhosis | 5 | 8 | null | 0 | 12,254 | 6,517.3008 | null | 8 | white | 22.097656 | 19 | 0.797974 | 0.674927 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 7 | 80 | 14 | 120 | 20 | 36.19531 | 260 | null | null | 0.799927 | 142 | 7.449219 | null | null | null | 6 | null | null | 4.527397 |
696 | 77.85895 | 1 | female | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 89,858 | 41,205.5625 | null | 39 | white | 28.699219 | 76 | 0.338989 | 0.222992 | 3 | 0 | 0 | metastatic | 0.25 | 0.05 | dnr before sadm | -1 | 58 | 8.699219 | 165 | 16 | 38.79688 | 91.10938 | 1.699951 | 0.899902 | 1.5 | 143 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.657227 |
697 | 71.02295 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 0 | 132,772 | 59,345.3438 | null | 30.666656 | white | 29.199219 | 50 | 0.620972 | 0.515991 | 8 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 13 | 110 | 10.298828 | 140 | 23 | 38.19531 | 126.3125 | null | 2 | 1.799805 | 137 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 2.482422 |
698 | 30.35999 | 0 | male | 0 | 12 | 1,425 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 37 | 283,773 | 137,584.625 | null | 44.5 | black | 29.699219 | 38 | 0.667969 | 0.570923 | 13 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 12 | 100 | 17 | 115 | 10 | 37.79688 | 332.5 | 2.199707 | 27.398438 | 1 | 136 | 7.389648 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
699 | 76.74194 | 1 | male | 0 | 5 | 349 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | null | 0 | 14,066 | 7,114.2422 | null | 14 | white | 18.097656 | 38 | 0.8479 | 0.75 | 1 | 1 | 0 | no | null | null | no dnr | 5 | 58 | 7.799805 | 70 | 20 | 36.5 | null | null | null | 1.599854 | 135 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.955078 |
700 | 76.97198 | 0 | female | 0 | 6 | 1,424 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | >$50k | 0 | 11,489 | 6,593.7188 | null | 10 | black | 18.296875 | 21 | 0.844971 | 0.744995 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 85 | 4.699219 | 100 | 20 | 36.5 | 352.375 | null | null | 1.599854 | 139 | 7.449219 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |